Seeing Is Believing
Currently out of the existing stock ratings of Jessica Tassan, 40 are a HOLD (21.05%), 2 are a SELL (1.05%), 148 are a BUY (77.89%).
Analyst Jessica Tassan, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 54.59% that have a potential upside of 21.07% achieved within 125 days.
Jessica Tassan’s has documented 374 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on UNH, UnitedHealth Group at 14-Oct-2026.
Analyst best performing recommendations are on NXGN (NEXTGEN HEALTHCARE).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
$11.72 (4185.71%)
2 years 11 months 12 days ago
(17-Nov-2023)
0/1 (0%)
$4.37 (57.27%)
Hold
$0.5
$0.25 (100.00%)
$2.5
3 years 2 months 15 days ago
(14-Aug-2023)
0/5 (0%)
$3.12 (70.54%)
Buy
$0.8
$0.55 (220.00%)
$12
3 years 2 months 18 days ago
(11-Aug-2023)
0/3 (0%)
$3.48 (64.74%)
Buy
$17
3 years 2 months 18 days ago
(11-Aug-2023)
0/1 (0%)
$4.88 (40.26%)
Buy
3 years 6 months 27 days ago
(03-Apr-2023)
4/4 (100%)
$2.26 (47.68%)
338
Which stock is Jessica Tassan most bullish on?
Which stock is Jessica Tassan most reserved on?
What Year was the first public recommendation made by Jessica Tassan?